Sutro Biopharma, Inc.
STRO
$40.05
-$0.86-2.10%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.76% | -394.45% | 84.86% | -4.87% | -48.49% |
| Total Depreciation and Amortization | -14.53% | 0.00% | 0.00% | 1.71% | 3.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.72% | -21.59% | 0.82% | 5.21% | 240.01% |
| Change in Net Operating Assets | 0.65% | 109.19% | -453.04% | 41.87% | -121.00% |
| Cash from Operations | 30.78% | 14.61% | 34.12% | 5.37% | -11.19% |
| Capital Expenditure | 26.69% | -191.86% | 92.67% | -9.93% | -28.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.07% | 1,409.38% | 117.67% | -117.03% | -40.21% |
| Cash from Investing | -53.23% | 1,449.96% | 115.87% | -118.58% | -40.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.64% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -168.00% | 58.33% | 66.67% | -650.00% | 67.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -162.75% | 270.00% | -190.91% | 375.00% | -102.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -509.94% | 104.51% | 49.80% | -634.62% | -81.23% |